Pharmaceutical Industry

LRK Laboratoire homéopathique de recherches Kurtoglu SA 

Cugy Vd · Since 1977

Laboratoire LRK SA develops, manufactures and distributes a wide range of products for the healthcare industry, particularly in the fields of naturopathy and alternative medicine. The core activities include research and development of therapeutic products, the production of homeopathic remedies, gemmotherapy products, micronutrients, Synergia products and René Quinton's sea products, as well as the organization of continuing education events for healthcare professionals.

Oligopharm SA 

Cugy Vd · Since 1986

Oligopharm is a laboratory specializing in analysis, focusing on hair analysis. Additionally, it offers certifications and training opportunities. The company's core activity is the scientific analysis of hair samples to provide information on health and body condition.

PLT Phi-Lambda-Technology GmbH 

Menziken · Since 1999

PLT Phi-Lambda-Technology GmbH produces and distributes bioenergetic products for people, animals and plants that do not contain chemical ingredients. Offerings include water enhancers, skincare products, room crystals and items for aura protection, as well as products intended to support vitality and regeneration.

PROREGIA AG 

Kestenholz · Since 2020

QUADIRA BIOSCIENCES AG 

Solothurn · Since 2021

Sanofi-Aventis (Suisse) SA 

Vernier · Since 1998

The core activity of Sanofi is the development, manufacture and marketing of therapeutic solutions, vaccines and health products. In particular, the company focuses on the following areas: Specialty Care: immunology, rare diseases, rare blood diseases, oncology, neurology and multiple sclerosis; Vaccines: prevention options against infectious diseases in children, adolescents and adults; General Medicines: diabetes, cardiovascular diseases, transplants and infectious diseases; Consumer Health Care: pain, winter diseases and digestive problems. The company thus offers a wide range of health solutions aimed at improving the lives of patients.

SANOLA Services AG 

Sisseln Ag · Since 2009

Die Übersetzungen lauten wie folgt: **Unternehmen 1:** The company's core activity lies in the pharmaceutical production sector and related infrastructure, with a specialization in consulting and services in various matters. **Unternehmen 2 (Sanola Services AG):** The company's core activity includes services in the fields of ventilation and dedusting technology, air conditioning and refrigeration systems, catafalque, as well as consulting, engineering, fire protection and qualification in connection with these technologies.

Contrad Swiss SA 

Lugano · Since 2011

The core activity of Contrad Swiss is the development, manufacture and marketing of pharmaceutical products and medical devices, particularly in the area of self-medication (OTC) and regenerative aesthetics, with a focus on improving the health and quality of life of consumers and patients.

Debiopharm Research & Manufacturing SA 

Martigny · Since 1988

Debiopharm Research & Manufacturing SA is a pharmaceutical research, development and production facility inspected and registered with major regulatory authorities. It develops and manufactures PLGA-based injectable sustained‑release formulations (1‑, 3‑ and 6‑month releases) and pursues nanoparticulate drug‑delivery systems.

Doetsch Grether AG 

Basel · Since 1996

Doetsch Grether AG is a healthcare company that develops, markets and distributes brands and products in the pharmaceutical, OTC and consumer care sectors. The company manages a portfolio of proprietary and exclusive international brands, supplies pharmacies, drugstores and retail, and organises its operations into the business units Consumer Health, Pharma and Vita Health Care.

Eumedica Pharmaceuticals AG 

Basel · Since 1995

The core activity of Eumedica Pharmaceuticals AG is the development, manufacture and marketing of pharmaceuticals, particularly established products for rare and severe diseases. The company focuses on addressing critical unmet medical needs and offers a broad range of therapeutic solutions distributed in over 36 countries.

GlaxoSmithKline AG 

Baar · Since 1952

GlaxoSmithKline AG develops and markets specialty and general medicines as well as vaccines to prevent and treat disease. The company’s therapeutic focus areas include respiratory conditions, immunology and inflammation, oncology, HIV and infectious diseases.

GMT Fine Chemicals SA 

Couvet · Since 1997

The core activity of GMT Fine Chemicals SA is the production of therapeutically active substances, in particular reduced folates, which are used in the manufacture of pharmaceuticals, primarily in oncology and gynecology.

AeoniQ Holding AG 

Schlieren · Since 2023

AeoniQ Holding AG offers the AeoniQ™ technology, a climate-positive continuous cellulosic filament yarn intended to replace polyester and nylon in textile applications.

HeiQ GrapheneX AG 

Schlieren · Since 2019

HeiQ GrapheneX AG develops porous graphene materials synthesized directly via a scalable Chemical Vapor Deposition (CVD) process. The materials combine atomically thin, high‑strength and conductive graphene with engineered porosity and are intended for membrane applications such as water filtration, electronic vents and lithium‑metal battery electrodes.

IDEOGEN AG 

Hurden · Since 2013

IDEOGEN AG is a pharmaceutical services company that partners with biotech and pharmaceutical organisations to enable access to specialty therapeutics and provide commercial and medical support. Its services include managed-access and early-access programmes, supply and distribution for licensed and unlicensed medicines, pharmacovigilance, and research & development support.

IDEOGEN GROUP GmbH 

Hurden · Since 2021

IDEOGEN GROUP GmbH is a family-owned Swiss pharmaceutical group that facilitates access to specialty medicines for unmet medical needs. The company provides commercialization and distribution of licensed and unlicensed products, manages early-access and named‑patient programs, and delivers regulatory, pharmacovigilance and operational services including GMP/GDP and wholesale distribution capabilities.

Avyxa GmbH 

Barbengo · Since 2004

The core activity of Ingenus Pharmaceuticals is the development, manufacture and marketing of generic medicines as cost-effective solutions for patients, suppliers and other stakeholders in the healthcare sector.

Intex-Biotech AG 

Basel · Since 2001

The core activity of INTEX Biotech AG is the manufacture and development of pharmaceutical, immunological and medical diagnostic products, particularly point-of-care tests (rapid diagnostics) for various applications such as pregnancy tests, ovulation tests, tumor tests, drug tests and infection tests.

Jetpharma SA 

Balerna · Since 1986

The core activity of Jetpharma SA is the micronization of pharmaceutical active ingredients and excipients on behalf of third parties, in particular the micronization of highly active and cytotoxic substances, such as medicinal products, inert substances, HPAIs, cytotoxic and cytostatic substances, steroids and psychotropic substances.